LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.31 | 27.76 | 5736 | 6976 | 0.8222 | 0.9515 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.31 | 27.76 | 7846 | 6976 | 1.1247 | 1.0297 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.31 | 27.76 | 8620 | 6976 | 1.2356 | 1.0538 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.31 | 27.76 | 9659 | 6976 | 1.3846 | 1.0833 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.01 | 27.76 | 4476 | 7000 | 0.6394 | 0.8910 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.01 | 27.76 | 7973 | 7000 | 1.1389 | 1.0329 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.01 | 27.76 | 7710 | 7000 | 1.1014 | 1.0244 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.01 | 27.76 | 9702 | 7000 | 1.3859 | 1.0835 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 83.72 | 27.76 | 4616 | 7055 | 0.6542 | 0.8966 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 83.72 | 27.76 | 8076 | 7055 | 1.1446 | 1.0341 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 83.72 | 27.76 | 6733 | 7055 | 0.9543 | 0.9883 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 83.72 | 27.76 | 9743 | 7055 | 1.3809 | 1.0824 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 85.42 | 27.76 | 3973 | 7025 | 0.5655 | 0.8622 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 85.42 | 27.76 | 8180 | 7025 | 1.1643 | 1.0385 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 85.42 | 27.76 | 5900 | 7025 | 0.8398 | 0.9567 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 85.42 | 27.76 | 9729 | 7025 | 1.3848 | 1.0832 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.13 | 27.76 | 3063 | 6987 | 0.4383 | 0.8035 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.13 | 27.76 | 8216 | 6987 | 1.1758 | 1.0410 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.13 | 27.76 | 5076 | 6987 | 0.7264 | 0.9214 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 87.13 | 27.76 | 9755 | 6987 | 1.3960 | 1.0854 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.84 | 27.76 | 2289 | 6965 | 0.3286 | 0.7394 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.84 | 27.76 | 8287 | 6965 | 1.1898 | 1.0441 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.84 | 27.76 | 3189 | 6965 | 0.4579 | 0.8133 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.84 | 27.76 | 9743 | 6965 | 1.3989 | 1.0860 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.55 | 27.76 | 2024 | 6928 | 0.2921 | 0.7136 | MN20160318_Q01 | E09 |